Doctors seek perfect dose to numb shoulders with less medicine
NCT ID NCT07338916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks for the smallest amount of numbing medicine that works for a shoulder nerve block during surgery. About 55 adults having shoulder arthroscopy will take part. Researchers will test different doses to find the minimum effective volume, aiming to improve safety and reduce side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 55 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * ASA physical status I to III * Body Mass Index (BMI) between 18 and 35 kg/m² * Weight ≥ 50 kg * Scheduled for shoulder arthroscopy requiring an interscalene brachial plexus block for analgesia * Able to provide informed consent Exclusion Criteria: * Inability to provide informed consent * Coagulopathy (platelet count ≤100,000; INR ≥1.4) * Significant pulmonary disease (restrictive or obstructive) * Renal insufficiency (creatinine ≥1.2 mg/dL) * Hepatic insufficiency (transaminases ≥100 U/L) * Allergy to local anesthetics * Pregnancy * Pre-existing neuropathy * Previous surgery in ipsilateral cervical or supraclavicular region * Contralateral hemidiaphragmatic paralysis or vocal cord paralysis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brachial plexus blockade are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital del Trabajador
RECRUITINGProvidencia, Chile
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Iodine-coated surgical drapes may cut infection risk in shoulder replacements
- New pain block approach could improve shoulder surgery recovery
- New study aims to find safer pain block for shoulder surgery
- New pain monitor tested for nerve block success during surgery
- Could a tiny nerve zap replace opioids after shoulder surgery?
- Shoulder surgery patients report less pain with nerve block